Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Acute Central Serous Chorioretinopathy
NCT06809751Phase 3Not yet recruiting
- Start
- Feb 2025
- Primary completion
- May 2025
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of melatonin in Central Serous Chorioretinopathy (CSCR). Planned start Feb 2025; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT06809751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06809751.